Thrivent Financial for Lutherans Purchases 11,428 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Thrivent Financial for Lutherans lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 10.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 116,843 shares of the company's stock after buying an additional 11,428 shares during the period. Thrivent Financial for Lutherans owned about 0.09% of Henry Schein worth $8,085,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in HSIC. Smartleaf Asset Management LLC lifted its position in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares during the period. CIBC Asset Management Inc lifted its position in Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock worth $1,235,000 after purchasing an additional 169 shares during the period. Studio Investment Management LLC boosted its stake in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock worth $341,000 after buying an additional 172 shares in the last quarter. Metis Global Partners LLC increased its holdings in Henry Schein by 4.7% in the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after buying an additional 187 shares during the period. Finally, Central Pacific Bank Trust Division raised its stake in shares of Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock valued at $706,000 after buying an additional 200 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Activity

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.37 during trading on Wednesday, reaching $69.75. The company had a trading volume of 922,231 shares, compared to its average volume of 1,504,998. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The business's 50 day moving average price is $74.79 and its 200-day moving average price is $72.65. The stock has a market cap of $8.66 billion, a PE ratio of 28.70, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 EPS. Analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on HSIC shares. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 target price for the company. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and boosted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective for the company. Finally, UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.